A lot of people will have read in the media regarding the claim that there might be a link with the Astra Zeneca covid-19 vaccination causing blood clots. This has resulted in a number of European countries suspending the roll out of the vaccine.
Please be reassured that Astra Zeneca have undertaken a careful review of all available safety data of more than 17 million people vaccinated in the European Union (EU) and UK with COVID-19 Vaccine AstraZeneca. There has been no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country.
So far across the EU and UK, there have been 15 events of DVT and 22 events of pulmonary embolism reported among those given the vaccine, based on the number of cases the Company has received as of 8 March. This is much lower than would be expected to occur naturally in a general population of this size and is similar across other licensed COVID-19 vaccines.